Literature DB >> 8085664

Klinefelter's syndrome: new and rapid diagnosis by PCR analysis of XIST gene expression.

A Kleinheinz1, W Schulze.   

Abstract

Diagnosis of Klinefelter's syndrome relies on raised gonadotropin levels in serum, azoospermia, determination of sex chromatin in oral swabs and finally chromosome analysis in leukocyte cell culture. By this method the numerical chromosome aberration with a 47, XXY karyotype can be detected. However, diagnosis can be accelerated by demonstration of RNA expression of an X-linked gene, which serves as a marker for inactivation of the second and any further extra X chromosome in the cell. This so-called X-inactive-specific transcript (XIST) is transcribed exclusively from the inactive X chromosome. RNA was isolated both from Ficoll-prepared peripheral blood leukocytes and from total EDTA blood of Klinefelter patients and control persons. RNA was reverse transcribed and finally detected by the polymerase chain reaction (PCR) with XIST-specific sequences. The pyruvate dehydrogenase gene was used as a control gene for successful RNA preparation and reverse transcription. XIST transcripts could be detected in all blood samples from Klinefelter patients (n = 15, karyotype 47, XXY) and female persons (n = 3). Fertile men (n = 5) were negative for this transcript in peripheral blood. Thus, diagnosis of Klinefelter's syndrome can be accelerated without loss of sensitivity and specificity by detection of XIST expression in peripheral blood leukocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085664     DOI: 10.1111/j.1439-0272.1994.tb00773.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  8 in total

Review 1.  [Fertility in patients with Klinefelter syndrome (47,XXY)].

Authors:  S Kliesch; M Zitzmann; H M Behre
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 2.  Expression and function of a large non-coding RNA gene XIST in human cancer.

Authors:  Sarah M Weakley; Hao Wang; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

3.  Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition.

Authors:  Marquis P Vawter; Philip D Harvey; Lynn E DeLisi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

4.  Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.

Authors:  Roshan Fatima; Vijay Suresh Akhade; Debosree Pal; Satyanarayana Mr Rao
Journal:  Mol Cell Ther       Date:  2015-06-12

Review 5.  Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism.

Authors:  M Bonomi; V Rochira; D Pasquali; G Balercia; E A Jannini; A Ferlin
Journal:  J Endocrinol Invest       Date:  2016-09-19       Impact factor: 4.256

6.  Transcriptome analysis of the adult human Klinefelter testis and cellularity-matched controls reveals disturbed differentiation of Sertoli- and Leydig cells.

Authors:  Sofia Boeg Winge; Marlene Danner Dalgaard; Kirstine G Belling; Jacob Malte Jensen; John Erik Nielsen; Lise Aksglaede; Mikkel Heide Schierup; Søren Brunak; Niels Erik Skakkebæk; Anders Juul; Ewa Rajpert-De Meyts; Kristian Almstrup
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

7.  Pseudoautosomal Region 1 Overdosage Affects the Global Transcriptome in iPSCs From Patients With Klinefelter Syndrome and High-Grade X Chromosome Aneuploidies.

Authors:  Veronica Astro; Maryam Alowaysi; Elisabetta Fiacco; Alfonso Saera-Vila; Kelly J Cardona-Londoño; Riccardo Aiese Cigliano; Antonio Adamo
Journal:  Front Cell Dev Biol       Date:  2022-02-03

8.  Next Generation Sequencing expression profiling of mitochondrial subunits in men with Klinefelter syndrome.

Authors:  Michele Salemi; Laura Cimino; Marika Marino; Rossella Cannarella; Rosita A Condorelli; Corrado Romano; Sandro La Vignera; Aldo E Calogero
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.